Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, PD, and Comparative Bioavailability of THRV-1268 in Obese Adult Participants
Clinical trial NCT07186946 · COMPLETED
Trial details
- NCT number
- NCT07186946
- Sponsor
- Thryv Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2025-10-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.